In early 2024, the bird influenza that had been spreading across the globe for nearly three decades did something wholly ...

Each year, seasonal flu sickens about 1 billion people worldwide and causes approximately 290,000 to 650,000 respiratory ...

The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

Although most of the reported human infections from the USA so far 1,2 have been mild, the virus can change its profile rapidly. To reduce mortality and morbidity from influenza in humans, vaccines ...

Researchers conducted a study to determine the vaccine effectiveness of the 2023 to 2024 influenza vaccine across age groups and by virus type and subtype.

In the past two years, a disease-causing strain of avian flu, known as H5N1 or bird flu, has impacted 1,046 flocks across the ...

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...

Objective: This study aimed to analyze the genetic evolution and molecular characteristics of H5, H7, and H9 subtypes of avian influenza viruses in the external environment of poultry in Jining from ...

This paper is an important contribution giving new insights into the structure, function, and immunogenicity of influenza virus neuraminidases. The paper presents convincing evidence supporting the ...

Avian influenza is “evolving in ways we haven ... and it continues to show new tricks,” Nelson tells The Verge. The virus is spreading widely in domestic and wild animals, while exact ...